Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGM282 in primary biliary cholangitis
NCT02026401Phase 2Completed
- Sponsor
- NGM Biopharmaceuticals
- Start
- Feb 2014
- Primary completion
- Dec 2014
- Countries
- 2
01
Overview
A Phase 2 trial of aldafermin in primary biliary cholangitis (PBC), sponsored by NGM Biopharmaceuticals. Started Feb 2014; status: completed.
02
Drugs
aldafermin
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT02026401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02026401.